| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 11.27 | 0.15 (+1.35%) | 8.81 - 15.95 | 357.0 thousand |
Market data as of 4:00PM 05/17/13. Quotes are delayed by at least 15 min.
| Open | 11.16 |
|---|---|
| Previous Close | 11.12 |
| Day's Range | 11.11 - 11.50 |
| Market Cap | 354.6M |
| Avg Volume (10 Day) | 337.0K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -2.88 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Fail |
| Increased shareholder value? | Fail |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Neutral |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Pass |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Amedisys Reports First Quarter Financial Results and Updates 2013 Guidance
Business Wire - Tuesday 04/30/2013 7:00 AM ET
Amedisys Previews First Quarter 2013 Results
Business Wire - Thursday 04/25/2013 7:00 AM ET
| AMED | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -1.40% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.17 | |
| LT Debt/Equity | 0.09 | |
| Earnings Yield | -- | |
| Price/Sales | 0.24 |
| Company | Last | Change |
|---|---|---|
| Gentiva Health Services Inc | 9.99 | +1.52% |
| LHC Group Inc | 22.56 | +1.76% |
| Almost Family Inc | 19.77 | +0.82% |
| Addus Homecare Corp | 15.37 | +2.95% |
| Electromed Inc | 1.32 | -0.75% |
Data is delayed by at least 15 min.